Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

ClinicalTrials.gov ID: NCT01128894

Public ClinicalTrials.gov record NCT01128894. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 6:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label study examines the efficacy and safety of albiglutide as compared with liraglutide in subjects with type 2 diabetes.

Study identification

NCT ID
NCT01128894
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
841 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Aug 31, 2011
Completion
Aug 31, 2011
Last update posted
Feb 22, 2017

2010 – 2011

United States locations

U.S. sites
129
U.S. states
34
U.S. cities
111
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35294 —
GSK Investigational Site Chandler Arizona 85224 —
GSK Investigational Site Gilbert Arizona 85295 —
GSK Investigational Site Phoenix Arizona 85032 —
GSK Investigational Site Tucson Arizona 85712 —
GSK Investigational Site Searcy Arkansas 72143 —
GSK Investigational Site Chula Vista California 91910 —
GSK Investigational Site Escondido California 92026 —
GSK Investigational Site Fresno California 93720 —
GSK Investigational Site Huntington Beach California 92648 —
GSK Investigational Site Indio California 92201 —
GSK Investigational Site Irvine California 92618 —
GSK Investigational Site Los Angeles California 90017 —
GSK Investigational Site Los Angeles California 90022 —
GSK Investigational Site Mission Viejo California 92691 —
GSK Investigational Site Orange California 92868 —
GSK Investigational Site Palm Desert California 92260 —
GSK Investigational Site Riverside California 92506 —
GSK Investigational Site San Diego California 92120 —
GSK Investigational Site San Diego California 92128 —
GSK Investigational Site Satna Monica California 90404 —
GSK Investigational Site Spring Valley California 91978 —
GSK Investigational Site Tarzana California 91356 —
GSK Investigational Site Tustin California 92780 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site West Hills California 91307 —
GSK Investigational Site Clearwater Florida 33765 —
GSK Investigational Site Cocoa Florida 32927 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site North Miami Florida 33161 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Orlando Florida 32822 —
GSK Investigational Site Pembroke Pines Florida 33026 —
GSK Investigational Site St. Petersburg Florida 33709 —
GSK Investigational Site Tampa Florida 33613 —
GSK Investigational Site Winter Park Florida 32789 —
GSK Investigational Site Winter Park Florida 32792 —
GSK Investigational Site Atlanta Georgia 30309 —
GSK Investigational Site Atlanta Georgia 30312 —
GSK Investigational Site Atlanta Georgia 30338 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Blue Ridge Georgia 30513 —
GSK Investigational Site Roswell Georgia 30076 —
GSK Investigational Site Stone Mountain Georgia 30088 —
GSK Investigational Site Honolulu Hawaii 96814 —
GSK Investigational Site Idaho Falls Idaho 83404 —
GSK Investigational Site La Grange Illinois 60525 —
GSK Investigational Site Evansville Indiana 47714 —
GSK Investigational Site Valparaiso Indiana 46383 —
GSK Investigational Site Council Bluffs Iowa 51501 —
GSK Investigational Site Dubuque Iowa 52001 —
GSK Investigational Site Lexington Kentucky 40504 —
GSK Investigational Site Paducah Kentucky 42003 —
GSK Investigational Site Covington Louisiana 70433 —
GSK Investigational Site Shreveport Louisiana 71101 —
GSK Investigational Site Haverhill Massachusetts 01830 —
GSK Investigational Site Bloomfield Hills Michigan 48302 —
GSK Investigational Site Dearborn Michigan 48124 —
GSK Investigational Site Detroit Michigan 48235 —
GSK Investigational Site Kalamazoo Michigan 49009 —
GSK Investigational Site Kalamazoo Michigan 49048 —
GSK Investigational Site Saint Clair Shores Michigan 48081 —
GSK Investigational Site Minneapolis Minnesota 55430 —
GSK Investigational Site Picayune Mississippi 39466 —
GSK Investigational Site Kansas City Missouri 64111 —
GSK Investigational Site St Louis Missouri 63110 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Lincoln Nebraska 68516 —
GSK Investigational Site Omaha Nebraska 68131 —
GSK Investigational Site Las Vegas Nevada 89102 —
GSK Investigational Site Las Vegas Nevada 89103 —
GSK Investigational Site Elizabeth New Jersey 07202 —
GSK Investigational Site Haddon Heights New Jersey 08035 —
GSK Investigational Site North Massapequa New York 11758 —
GSK Investigational Site Staten Island New York 10301 —
GSK Investigational Site Burlington North Carolina 27215 —
GSK Investigational Site Durham North Carolina 27710 —
GSK Investigational Site Greensboro North Carolina 27405 —
GSK Investigational Site Lenoir North Carolina 28645 —
GSK Investigational Site Morehead City North Carolina 28557 —
GSK Investigational Site Shelby North Carolina 28150 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Canal Fulton Ohio 44614 —
GSK Investigational Site Cleveland Ohio 44122 —
GSK Investigational Site Columbus Ohio 43213 —
GSK Investigational Site Dayton Ohio 45439 —
GSK Investigational Site Gallipolis Ohio 45631 —
GSK Investigational Site Kettering Ohio 45429 —
GSK Investigational Site Oklahoma City Oklahoma 73103 —
GSK Investigational Site Portland Oregon 97239 —
GSK Investigational Site Downington Pennsylvania 19335 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Murrells Inlet South Carolina 29576 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Clarksville Tennessee 37043 —
GSK Investigational Site Memphis Tennessee 38125 —
GSK Investigational Site Tullahoma Tennessee 37398 —
GSK Investigational Site Arlington Texas 76012 —
GSK Investigational Site Corpus Christi Texas 78404 —
GSK Investigational Site Dallas Texas 75230 —
GSK Investigational Site Dallas Texas 75246 —
GSK Investigational Site Dallas Texas 75251 —
GSK Investigational Site Fort Worth Texas 76104 —
GSK Investigational Site Houston Texas 77036 —
GSK Investigational Site Houston Texas 77074 —
GSK Investigational Site Houston Texas 77088 —
GSK Investigational Site Hurst Texas 76054 —
GSK Investigational Site Katy Texas 77450 —
GSK Investigational Site Midland Texas 79707 —
GSK Investigational Site North Richland Hills Texas 76180 —
GSK Investigational Site San Antonio Texas 78215 —
GSK Investigational Site San Antonio Texas 78217 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site San Antonio Texas 78237 —
GSK Investigational Site Schertz Texas 78154 —
GSK Investigational Site Sugarland Texas 77479 —
GSK Investigational Site Bountiful Utah 84010 —
GSK Investigational Site Draper Utah 84020 —
GSK Investigational Site West Jordan Utah 84088 —
GSK Investigational Site South Burlington Vermont 05403 —
GSK Investigational Site Burke Virginia 22015 —
GSK Investigational Site Manassas Virginia 20110 —
GSK Investigational Site Richmond Virginia 23225 —
GSK Investigational Site Richmond Virginia 23294 —
GSK Investigational Site Salem Virginia 24153 —
GSK Investigational Site Spokane Washington 99208 —
GSK Investigational Site Spokane Washington 99216 —
GSK Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01128894, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2017 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01128894 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →